Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Bronchospasm in asthma, bronchitis, chronic bronchitis, ephysema, and bronchiectasis. Clinical selection for Fenoterol should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Inhaler: 2 inhalations (100 or 200 mcg) TID or QID (Max. 8 inhalations of the 100 mcg per metered spray formulation or 6 inhalations of the 200 mcg per metered spray formulation per day). Not to be administered more often than every four hours. Dosage should not exceed
Tachycardia, skeletal muscle cramp, palpitation, headaches, severe emotional disturbances, resistance after prolonged use, acidosis, GI disturbances, hypokaleamia, sweat
Store as labelled. Keep out of reach of children.